Form 4 for ONCY ONCOLYTICS BIOTECH INC
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-12 · accession 0001493152-26-006543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-12 | ONCY | Hagerman Allison | VP, Product Development | P - Purchase | $0.83 | +10.0K | 115.1K | +10% | +$8,300 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-02-12 | P | A | 10,000 | $0.83 | 115,059 | D | — | — |